Stem Cell Therapy for Myocardial Infarction: A Mini-Review

Stem cell therapy for myocardial infarction.

Cell therapy for age-related disorders: myocardial infarction and stroke--a mini-review.

BACKGROUND The leading causes of death and disability in the elderly are from cardiovascular and cerebrovascular diseases. The biological role of stem cells in the hematopoietic system has been well characterized and has led to the development of hematopoietic stem and progenitor cell (HSPC) transplantation for the treatment of numerous malignant and nonmalignant diseases. More recently, stem c...

Stem Cells Therapy for Acute Myocardial Infarction: A Literature Review

Received: August 20, 2009 Accepted for publication: Ocotber 21, 2009 From the Division of Cardiology, Department of Interal Medicine, Shin Kong Wu Ho-Su Memorial Hospital 2 Fu Jen Catholic University School of Medicine Graduate Institute of Clinical Medicine, Taipei Medical University Address reprint requests and correspondence: Dr. Kou-Gi Shyu Division of Cardiology, Department of Interal Medi...

[Stem cell therapy in acute myocardial infarction].

Remodeling of the left ventricle after myocardial infarction represents a major cause of infarct-related heart failure and death. Experimental data suggest that bone marrow-derived cells may contribute to the healing of myocardial infarction. The selective intracoronary transplantation of autologous, mononuclear bone marrow cells is safe and seems to be effective under clinical conditions conce...

Oxygen and oxygenation in stem-cell therapy for myocardial infarction.

Myocardial infarction (MI) is caused by deprivation of oxygen and nutrients to the cardiac tissue due to blockade of coronary artery. It is a major contributor to chronic heart disease, a leading cause of mortality in the modern world. Oxygen is required to meet the constant energy demands for heart contractility, and also plays an important role in the regulation of heart function. However, re...